Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MARAVIROC for Progressive multifocal leukoencephalopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where MARAVIROC was used for Progressive multifocal leukoencephalopathy.

Most Reported Side Effects for MARAVIROC

Side Effect Reports % Deaths Hosp.
Virologic failure 103 8.8% 0 13
Viral mutation identified 89 7.6% 2 0
Pathogen resistance 83 7.1% 0 1
Drug resistance 71 6.0% 1 0
Off label use 66 5.6% 18 9
Drug ineffective 57 4.8% 5 11
Exposure during pregnancy 55 4.7% 0 11
Treatment noncompliance 53 4.5% 2 1
Maternal exposure during pregnancy 39 3.3% 0 2
Death 36 3.1% 36 3
Nausea 31 2.6% 3 17
Condition aggravated 30 2.6% 6 6
Foetal exposure during pregnancy 30 2.6% 0 5
Abortion spontaneous 29 2.5% 0 1
Treatment failure 29 2.5% 0 1

Other Indications for MARAVIROC

Hiv infection (733) Product used for unknown indication (219) Prophylaxis against hiv infection (22) Antiretroviral therapy (16) Acquired immunodeficiency syndrome (13) Prophylaxis against graft versus host disease (13) Covid-19 (12) Acute hiv infection (9) Perinatal hiv infection (9) Post-acute covid-19 syndrome (8)

Other Drugs Used for Progressive multifocal leukoencephalopathy

MIRTAZAPINE (231) MEFLOQUINE (77) FILGRASTIM (44) PEMBROLIZUMAB (43) CIDOFOVIR (27) HUMAN IMMUNOGLOBULIN G (18) METHYLPREDNISOLONE (18) CYTARABINE (11) ATEZOLIZUMAB (7) PREDNISONE (7)

Related Pages

MARAVIROC Full Profile All Progressive multifocal leukoencephalopathy Drugs MARAVIROC Demographics MARAVIROC Timeline